Ads
related to: tecartus car t-cell therapy- How This Treatment Works
Get Info On Lymphoma
Treatment & See How It Works
- Safety & Side Effects
Read Important Safety And Possible
Side Effects Information.
- Real Patient Stories
Hear How Cell Therapy Could Help
From Real Patients And Caregivers
- Take The Quiz
Find Out If This Treatment Option
Is Right For You
- Dosing Information
View Recommended Dosing Schedules
For This Treatment Option.
- Clinical Trial Results
Find Info On Clinical Trials
For This Treatment Option.
- How This Treatment Works
Search results
CAR T-Cell Therapies Under FDA Watch on Reports of Malignancies
Zacks via Yahoo Finance· 6 months agoThe FDA has undertaken an investigation of T-cell malignancies in patients undergoing CAR T-cell...
Kite's Tecartus CAR T-Cell Therapy Demonstrates Durable Overall Survival Benefit In Leukemia...
Benzinga via Yahoo Finance· 1 year agoKite, a Gilead Sciences Inc (NASDAQ: GILD) company, announced the three-year follow-up results from...
FDA warns of secondary cancer risk tied to CAR-T therapies that treat cancer
CNN via Yahoo News· 4 months agoThe US Food and Drug Administration has issued a new warning about the possible risk of secondary...
Gilead (GILD) Kite Reports Positive Data on CAR T-Cell Therapy
Zacks via Yahoo Finance· 1 year agoGilead Sciences’ GILD Kite announced encouraging three-year follow-up results from the ZUMA-3 study...
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell...
Benzinga via Yahoo Finance· 6 months agoTuesday, the FDA said it received reports of patients developing T-cell malignancies, including...
FDA orders new cancer warnings for CAR-T therapies
BioPharma Dive via Yahoo Finance· 4 months agoThe agency later modified its warning for Gilead's Tecartus, tweaking the label's language to reflect the fact that none of T cell malignancies in...
FDA says cancer treatment CAR-T therapy may increase risk of cancer
NBC News via Yahoo News· 4 months agoThe Food and Drug Administration this week told several drugmakers to add a boxed warning — the...
Kite Pharma's CAR T-Cell Therapy Wins European Approval In Refractory Leukemia Setting
Benzinga via Yahoo Finance· 2 years agoThe European Commission has approved Gilead Science Inc (NASDAQ: GILD) company Kite Pharma's CAR...
Gilead CAR-T cancer therapy capacity to quadruple by 2026
Reuters via Yahoo News· 2 months agoGilead Sciences will be able to quadruple production of its cell therapy cancer treatments by 2026...
Gilead's (GILD) Tecartus Gets EC Nod for New Cancer Indication
Zacks via Yahoo Finance· 2 years agoThe European Commission approves Gilead's (GILD) CAR T-cell therapy, Tecartus, for treating adult...
